IP Library › Patent Application 63292887
Patent Application Provisional
App. No. 63/292,887 · Confirmation No. 9333

METHODS FOR TREATMENT OF CD20-POSITIVE PROLIFERATIVE DISORDER WITH MOSUNETUZUMAB AND POLATUZUMAB VEDOTIN

Applicant: Genentech, Inc.
Provisional Application Expired
⬇ PDF
 Code Description Pages PDF
2022-01-05 APP.FILE.REC Filing Receipt 3 View
2021-12-27 CRFE Sequence Listing in Computer Readable Format, No errors found 18 View
2021-12-22 SEQ.TXT Sequence Listing (Text File) 1 View
2021-12-22 PA.. Power of Attorney 2 View
2021-12-22 WFEE Fee Worksheet (SB06) 2 View
2021-12-22 N417 Electronic Filing System Acknowledgment Receipt 3 View
2021-12-22 CRFS CRF Statement that Sequence Listing text file (CRF) and paper/pdf Sequence Listing are the same 1 View
2021-12-22 TR.PROV Provisional Cover Sheet (SB16) 3 View
2021-12-22 ADS Application Data Sheet 9 View
2021-12-22 DRW Drawings-only black and white line drawings 2 View
2021-12-22 SPEC Specification 82 View
2021-12-22 CLM Claims 10 View
2021-12-22 ABST Abstract 1 View
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
App. No.
63/292,887
Filed
2021-12-22